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Homeostasis model
assessment (HOMA)Abstract Aim of the work: To assess the carotid artery intima–media thickness (IMT) as an index
of subclinical atherosclerosis in patients with primary osteoarthritis (OA) and its correlation to
severity and insulin resistance (IR).
Patients and methods: This study included 40 primary OA patients (28 with predominant knee
OA and 12 with hip OA) and 15 age and sex matched controls. They were subjected to full medical
history, thorough clinical examination and radiological assessment by plain X-rays of knee and hip
joints scored according to the Kellgren–Lawrence grading. In patients and control, the IR was cal-
culated by the homeostasis model assessment (HOMA) and carotid IMT measured by ultrasonog-
raphy.
Results: There was signiﬁcant increased carotid IMT in OA patients (0.82 ± 0.12 mm) com-
pared to controls (0.61 ± 0.02 mm) (p< 0.001) with cut-off value of 0.65 mm. There was signiﬁ-
cant higher HOMA in OA patients (2.55 ± 0.8) compared to controls (1.79 ± 0.44) (p< 0.001).
OA patients with IMT > 0.65 mm (n= 34) had longer duration (9 ± 2.56y), higher
Kellgren–Lawrence score (2.89 ± 0.45) and higher HOMA (3.8 ± 0.53) compared to those patients
with IMT < 0.65 mm (n= 6) (3.41 ± 2.09 y, 2.01 ± 0.26 and 2.23 ± 0.32 respectively). Multi-
regression analysis showed that disease duration, Kellgren–Lawrence Grading and HOMA are
the best sensitive discriminators for patients having carotid intima >0.65 mm. (F ratio 36.54,
p< 0.001).
86 N. Fouda et al.Conclusion: Osteoarthritis patients have higher risk of subclinical atherosclerosis independent of
traditional risk factors. The severity of OA may contribute to the progression of atherosclerotic dis-
ease. Measurement of insulin resistance in OA patients can identify those with higher risk of sub-
clinical atherosclerosis and may help in their follow up and early intervention.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis. Open access under CC BY-NC-ND license.1. Introduction
Osteoarthritis (OA) is the most common joint disease for
middle aged and older people. It is characterized by joint
pain and dysfunction [1]. Known risk factors for OA are
age, female gender, and obesity [2]. Recently, it has been
pointed out that OA is not a mere degenerative joint dis-
ease but a complex pathology that, besides the cartilage,
involves the synovial membrane and the subchondral bone
with a signiﬁcant local inﬂammatory reaction [3]. Further-
more, OA is also associated with an increase in comorbid
risk factors including cardiovascular disease (CVD) and
hypertension [4–6].
Atherosclerosis is an important feature of cardiometabolic
disorders. There are striking parallels between atherosclerosis
and osteoarthritis [7]. Common pathogenic features in affected
tissues include an abundance of activated macrophages,
cytokines, growth factors, adhesion molecules and matrix
metalloproteinases [8–10]. However, it is unclear whether
atherosclerosis and osteoarthritis are associated, either as
concurrent diseases due to a common etiology or are causally
related. Increasing evidence in the literature suggests that there
is a link between OA and atherosclerosis represented by the
pro-inﬂammatory state [11].
The carotid artery intima–media thickness (IMT), as mea-
sured non-invasively using B-mode ultrasound, has been pro-
posed as an early manifestation of atherosclerosis [12]. It
corresponds to the width of the vessel intima and media which
consists of endothelial cells, connective tissue and smooth mus-
cle. It is the site of lipid deposition in plaque formation. In-
creased IMT may pre-date the clinical manifestations of
atherosclerosis by many years in subjects at risk of atheroscle-
rosis and because of the non-invasive character and easy appli-
cability of the technique; it has been widely used in the
assessment of atherosclerosis [13].
The possibility that there can be defects in the sensitivity of
tissues to insulin action in people with diabetes was ﬁrst re-
ported nearly 50 years ago. Since then many investigators have
described, with increasing details, the pathogenesis and conse-
quences of what has become known as ‘‘insulin resistance’’
[14]. Insulin resistance is a common pathologic state in which
target cells fail to respond to ordinary levels of circulating
insulin. It is frequently associated with a number of diseases,
including chronic infection, obesity, type 2 diabetes and rheu-
matic diseases [15–18].
More recently, insulin resistance has been shown to be asso-
ciated with prevalent atherosclerosis. Thus, the recognition of
insulin resistance seems to have investigational and clinical rel-
evance in identifying subjects at high risk of CVD [19].
The aim of the work was to assess the carotid artery inti-
ma–media thickness (IMT) as an index of subclinical carotid
atherosclerosis in patients with primary osteoarthritis (OA)and its correlation to severity of OA and insulin resistance
(IR).2. Patients and methods
The present study is a cross sectional one that included 40
patients with primary OA fulﬁlled ACR criteria for diagnosis
of knee and hip OA [20,21]. Twenty-eight patients were diag-
nosed as primary knee OA mainly (70%) and 12 patients with
primary hip OA mainly (30%). They were selected from those
attending the Rheumatology and Rehabilitation outpatient
clinic in the Ain Shams University Hospitals.
Fifteen age and sex matched healthy subjects were also in-
cluded in the study and served as control group. The study was
approved by the local ethics committee and a written consent
was obtained from all patients and controls after a full expla-
nation of the study.
2.1. Exclusion criteria
– Hypertension, as deﬁned by blood pressure >140/90 mmHg
or use of antihypertensive drugs.
– Hyperlipidemia, as deﬁned by levels of total cholesterol
>250 mg/dl, low-density lipoprotein (LDL) >160 mg/dl,
or triglycerides >200 mg/dl, or the use of lipid-lowering
medications.
– Diabetes mellitus, as diagnosed according to the World
Health Organization criteria [22] either fasting blood glucose
>126 mg/dl (6.93 mmol/l) or use of anti-diabetic drugs.
– Patients with history of CVD, smokers and menopausal
females.
– Patients with secondary causes of OA were excluded from
this study e.g. trauma, congenital disorders and other rheu-
matic diseases e.g. Gout, rheumatoid arthritis (RA).2.2. Clinical assessment
– Full history taking laying stress on disease duration, family
or present history of any CVD and medication history.
– BMI (kg/m2) was determined by weight (kg) and height (m)
(Quelet index).
– Arterial blood pressure (BP) was measured three times, on
the ﬁrst two occasions with the subject in the sitting posi-
tion, one minute apart, while the third with the patient in
the supine position after four minutes, the mean value of
both systolic and diastolic arterial pressure was considered.2.3. Laboratory assessment
– Erythrocyte sedimentation rate (ESR) was done using
Westergren method.
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(HDL) and triglycerides were evaluated in blood samples
taken in the morning after 14 h fasting using standard enzy-
matic methods. Low density lipoprotein (LDL) was calcu-
lated by the formula of Friedewald et al. [23].
– Serum insulin was detected according to chemiluminescent
microparticle immunoassay. Insulin resistance (IR)was calcu-
lated by the homeostasismodel assessment (HOMA)based on
fasting plasma glucose and serum insulin concentration with
the formula that was deﬁned by Matthews [24] as follows:Homeostasis model assessment ðHOMAÞ
¼ ½Fasting Insulin ðlIU=mlÞ
 Fasting glucose ðmmol=lÞ=22:5:
with this method, high HOMA score shows low insulin
sensitivity.
2.4. Radiological assessment
Carotid ultrasound: Patients and controls were investigated for
subclinical atherosclerosis in the supine position with the head
turned slightly away from the sonographer. The common car-
otid arteries were examined for the wall changes obtaining dif-
ferent longitudinal and transverse views with high resolution B
mode ultrasound (ALOKA 4500) using a linear array 10 MHz
probe. A region about 1.5 cm proximal to the carotid bifurca-
tion was identiﬁed and the intima media thickness (IMT) of
the far wall was evaluated as the distance between the lumi-
nal–intimal interface and the medial–adventitial interface
[25]. One transverse and two longitudinal measurements of
IMT were obtained from 10 contiguous sites at 1 mm intervals,
and the average of the 10 measurements was used for the anal-
ysis. Both right and left sides were examined and the average of
both readings was taken. All ultrasound measurements were
performed by sonographer unaware of subject characteristics.
The cut off value was deﬁned as a mean IMT+ 2SD of the
IMT values in the controls.
The presence of plaques in the carotid artery was assessed
by examining the ultrasonographic images of the common,
internal and bifurcation sites of the carotid artery for the pres-
ence of atherosclerotic lesions. Plaques were deﬁned as a focal
widening relative to adjacent segments, with protrusion into
the lumen composed of either only calciﬁed deposits or a com-
bination of calciﬁed and non-calciﬁed material [26].
Assessment of osteoarthritis: Plain X-rays anteroposterior
and lateral views of affected knee and hip joints were taken
with the patient standing and the patella in a central position.
Radiographs of the pelvis were obtained when both feet were
rotated 10 inward and the X-ray beam was centered on the
umbilicus. The severity of the osteoarthritis was assessed by
Kellgren–Lawrence Grading System [27] as follows:
Grade 1: doubtful narrowing of joint space and possible
osteophytic lipping
Grade 2: deﬁnite osteophytes, deﬁnite narrowing of joint
space
Grade 3: moderate multiple osteophytes, deﬁnite narrowing
of joints space, some sclerosis and possible deformity of
bone contourGrade 4: large osteophytes marked narrowing of joint
space, severe sclerosis and deﬁnite deformity of bone
contour.
Statistical analysis was done using ‘Statistical Package for
Social Science (SPSS) program version 21 (SPSS Inc., Chicago,
IL, USA) .Data were expressed as Mean ± SD for quantita-
tive parametric measures. Comparison between two indepen-
dent mean groups for parametric data was performed using
Student t test. The probability of error at 0.05 was considered
sig., while at 0.01 and 0.001 are highly sig. Multi-regression
analysis was used to search for a panel (independent parame-
ters) that can predict the target parameter (dependant vari-
able). By using stepwise multi-regression analysis, parameters
among these panels can be sorted according to their sensitivity
to discriminate. Pearson correlation coefﬁcient (r) was used to
test correlation between two quantitative variables.3. Results
This study included 40 patients with primary OA, 30 females
(75%) and 10 males (25%), their ages ranged from 44 to
53 years with a mean of 49.53 ± 2.38 years. The disease dura-
tion ranged from 2 to 9 years with a mean of
5.53 ± 3.33 years. Twenty-eight patients were diagnosed as
primary knee OA mainly (70%) and 12 patients with primary
hip OA mainly (30%).
The controls were 11 females (73.3%) and 4 males (26.7%).
Their ages ranged from 43 to 52 years with a mean of
49.22 ± 2.21 years. There was a statistically non-signiﬁcant
difference between OA patients and controls as regards demo-
graphic and laboratory data (Table 1).
The carotid IMT was signiﬁcantly higher in OA patients
(0.83 ± 0.12 mm) compared to controls (0.61 ± 0.02 mm)
(t= 6.69, p< 0.001) with a cut off value of 0.65 mm. Osteo-
arthritic patients showed a signiﬁcant higher mean value of
HOMA (2.55 ± 0.8) compared to controls (1.79 ± 0.44)
(t= 4.05, p< 0.001) (Fig. 1).
There was a statistically non-signiﬁcant difference between
females and males OA patients as regards carotid IMT
(0.82 ± 0.13 mm and 0.81 ± 0.82 mm respectively) and mean
value of HOMA (2.55 ± 0.12 and 2.01 ± 0.52 respectively).
There was a statistically signiﬁcant correlation between
HOMA and both carotid IMT and BMI (r= 0.45 and 0.43
respectively, p< 0.05) while no statistically signiﬁcant correla-
tion was detected between HOMA and both the disease dura-
tion and Kellgren–Lawrence Grading for OA severity.
We recorded a statistically signiﬁcant correlation between
carotid IMT and BMI (r= 0.42, p< 0.05) and Kellgren–
Lawrence Grading for OA severity (r= 0.48, p< 0.05).
Also, a signiﬁcant correlation was present between carotid
IMT and the age in both OA patients and controls
(r= 0.65, p< 0.05) as older people had a signiﬁcantly
higher carotid IMT.
Osteoarthritis patients were divided into two groups
according to carotid IMT; those with a mean IMT< 0.65 mm
(6/40) and > 0.65 mm (34/40) respectively (Fig. 2). Compari-
son between both groups showed that patients with
IMT> 0.65 mm had higher HOMA, Kellgren–Lawrence
Grading and longer disease duration compared with those with
Table 1 Comparison between osteoarthritis patients and controls as regards demographic and laboratory data.
OA patients (n= 40) Controls (n= 15) t p
Age (years) 49.53 ± 2.38 49.22 ± 2.21 0.42 NS
BMI 27.10 ± 2.58 26.39 ± 2.65 0.86 NS
Systolic BP (mmHg) 121 ± 10.16 117 ± 11.61 1.19 NS
Diastolic BP (mmHg) 77 ± 5.84 75 ± 4.62 1.16 NS
Total cholesterol (mg/dl) 196 ± 17.39 188 ± 16.65 1.47 NS
Triglycerides (mg/dl) 111 ± 27.84 98 ± 23.86 1.54 NS
LDL (mg/dl) 97 ± 23.47 96 ± 28.98 0.12 NS
HDL (mg/dl) 41 ± 5.78 39 ± 6.22 1.07 NS
BMI = body mass index, BP = blood pressure, HDL= high density lipoprotein, LDL= low density lipoprotein.
Figure 1 Comparison between controls and osteoarthritis
patients as regards mean value of homeostasis model assessment
(HOMA).
Figure 2 Right common carotid artery with increased intima
media thickness (IMT) (a) IMT= 0.9 mm and (b) IMT= 1.1 mm
measured at longitudinal (left) and cross sectional (right) images.
The white arrows refer to the thickness.
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ence (Table 2).
Multi-regression analysis of factors associated with the car-
otid IMT in OA patients showed that disease duration, Kell-
gren–Lawrence Grading and HOMA are the best sensitive
discriminators for patients having carotid intima thickness
more than 0.65 mm as shown in Table 3 (F ratio 36.54,
p< 0.001).
4. Discussion
Osteoarthritis (OA) is a highly prevalent joint disorder that
causes a huge burden of pain and disability [28]. There is grow-
ing evidence that vascular disease might have a role in the
pathogenesis of OA [29]. More recently it was also found that
patients with OA are at higher risk of death from cardiovascu-
lar disease compared to the general population [30]. Tradi-
tional cardiovascular risk factors do not adequately account
for the extent of cardiovascular disease in OA. So, the relative
contributions of traditional and nontraditional risk factors to
cardiovascular disease in OA await elucidation [28].
Measurement of the intima–media thickness (IMT) of the
common carotid artery by high-resolution ultrasonography
has been established as a radiological useful index for identify-
ing subclinical atherosclerosis. The carotid IMT is strongly
correlated with the presence of coronary artery diseases [12].
The aim of this study was to assess the carotid IMT as an
index of subclinical carotid atherosclerosis in patients withprimary OA and its correlation to disease severity and insulin
resistance (IR).
In this study OA patients exhibited greater carotid IMT
compared with the controls pointing out the possibility of a
common background belonging to the degenerative and
inﬂammatory reactions in these patients. This increase oc-
curred independently of traditional risk factors as hyperten-
sion, diabetes mellitus, hyperlipidemia and smoking. Jonsson
et al. [9] previously demonstrated that hand osteoarthritis
and atherosclerosis were associated in older women in their
study on 2264 men and 3078 women diagnosed as localized
hand osteoarthritis. They hypothesized that circulatory distur-
bance in the synovial membrane and subchondral bone im-
paired the supply of nutrients to the overlying cartilage plate
and subsequent cartilage loss.
Table 2 Comparison between osteoarthritis patients with intima–media thickness (IMT)<0.65 mm and > 0.65 mm as regards
demographic, Kellgren–Lawrence Grading and homeostasis model assessment (HOMA).
IMT< 0.65 mm (n= 6) IMT> 0.65 mm (n= 34) t p
Age (years) 48.33 ± 6.59 48.58 ± 6.51 0.08 NS
BMI 26.45 ± 1.99 27.26 ± 1.99 0.92 NS
DD (years) 3.41 ± 2.09 9 ± 2.56 5.04 HS
KL grading 2.01 ± 0.26 2.89 ± 0.45 4.62 HS
HOMA 2.23 ± 0.32 3.8 ± 0.53 6.99 HS
BMI = body mass index, DD= disease duration, KL =Kellgren–Lawrence, HOMA= homeostasis model assessment, NS = non signiﬁ-
cant, HS = Highly signiﬁcant.
Table 3 Multiple regression analysis of factors associated with intima–media thickness of the common carotid artery in OA patients.
Regression coeﬃcient p F ratio Sig
Disease duration (years) 0.2288 0.00053 36.54 HS p< 0.001
KL grading 0.0182 0.21009
HOMA 0.1318 0.00032
KL=Kellgren–Lawrence, HOMA= homeostasis model assessment, HS = highly signiﬁcant.
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ﬁrmed also the associations between atherosclerosis indicated
by increased carotid IMT and osteoarthritis in several joints
in women. Kornaat et al. [8] recorded in 2009 increased
average popliteal artery wall thickness in patients with gen-
eralized OA than persons from the normal reference
population.
These results could be explained by the enhanced inﬂamma-
tion and oxidative stress emanating from the articular lesions
leading to vascular and metabolic effects that leads to
increased risk of atherosclerosis in OA patients [7]. In osteoar-
thritis, the subchondral bone might be affected by micro vas-
cular changes in both the arterial as well as the venous side
of the vascular circulation resulting in episodically reduced
blood ﬂow through the small vessels in the subchondral bone
and ﬁnally leading to subchondral ischemia [29]. Vascular dis-
ease in subchondral bone may also explain ﬂuctuation in sub-
chondral bone marrow edema lesions recently reported on MR
images in OA patients [8], as it may resemble episodes of avas-
cular necrosis.
The role of insulin resistance has not been extensively inves-
tigated in OA patients. In this study HOMA scores were signif-
icantly higher in all patients with OA than in control subjects.
The present data conﬁrm other previous ﬁndings [16–18] of an
increased insulin resistance in patients with rheumatic diseases
compared to controls. This can be explained by the fatigue and
muscle weakness induced by insulin resistance and the increase
in frequency and intensity of traumatic events of peripheral or
axial joints [31]. This results in stretching and breaking of teno-
periosteal junction and abrasive damage of cartilage and there-
fore the reparative process of cartilage and peri-articular tis-
sues would be difﬁcult due to the biochemical ‘‘soup’’
bathing the joints [32,33].
Patients with osteoarthritis frequently are complaining of
hotness and recurrent edema of feet and hands. It is probable
that hyperinsulinemia in the presence of insulin resistance and
inﬂammation, induce vasodilatation through the TNF medi-
ated-inducible nitric oxide synthase (iNOS) over expression
[34]. Keeping with the study of Dessein et al. [32] there wasa positive correlation between HOMA score and BMI in this
study.
In this study there was a signiﬁcant correlation between
HOMA and increased IMT in OA patients. This is also in con-
cordance with La Montagna study [33] who conﬁrmed this
correlation in his study on RA patients. Atherosclerosis acts
in many ways like an inﬂammatory condition with prominent
cellular inﬁltration and cytokine expression [35,36]. These ﬁnd-
ings indicate that insulin resistance seems to complicate OA via
an increase in atherosclerotic disease risk [15]. Given the
plausible relationships among insulin resistance and osteoar-
thritis, it was reasonable to pursue strategies that would treat
insulin resistance itself in OA patients. Focused research is re-
quired to identify the optimal regimens in these patients.
Data from other studies [37,38] on RA patients support our
observation of the association between disease duration which
reﬂect chronic inﬂammation and increased carotid IMT thick-
ness. Furthermore, as expected, we conﬁrmed a positive corre-
lation between carotid IMT and age, both in patients with OA
and in the normal reference population, and this correlation
has been described previously [39].
The presence of systemic inﬂammation caused by visceral
adipose tissue that secretes proinﬂammatory cytokines and
adipokines explains the positive correlation between BMI
and carotid IMT recorded in this study. These inﬂammatory
processes are involved in the aetiopathogenesis of atheroscle-
rosis [40,41].
The arterial wall changes progressed in the OA patients as
bone destruction progressed, as evidenced by a signiﬁcant po-
sitive association between the Kellgren–Lawrence Grading and
the carotid IMT by multiple regression analysis. In a popula-
tion study in Iceland, the severity of the atherosclerosis was
signiﬁcantly associated in females with hand OA [9]. Different
relations between the overall progression of knee osteoarthritis
and atherosclerosis have been reported previously [42].
The increase in carotid IMT in OA patients with high
Kellgren–Lawrence scores may be explained by an increase
in calcium mobilization from bone due to enhancement of
bone destruction, leading to enhanced development of
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order to describe how the severity of the atherosclerotic disease
may contribute to the progression of OA or vice versa, in bidi-
rectional relationship [40].
Whether carotid IMT is susceptible to rapid and potentially
reversible changes depending on the intensity of inﬂammation
remains unknown. If this is the case, an increased carotid IMT
in such disease may not reﬂect structural vessel wall damage.
Prospective; long-term, longitudinal studies are needed to ad-
dress this question. More researches are needed also to
elucidate the role of other non-traditional factors such as
endothelial dysfunction, impaired ﬁbrinolysis in addition to
oxidative stress.
However, the present study had a number of limitations.
We have not examined vasculature in the bones directly. So,
we have not been able to measure other local factors affecting
the vasculature. Another limitation is the absence of an analy-
sis of other potential cofounders such as diet, physical activity
and the symptomatic severity of OA. It is possible that patients
with OA experienced pain with movements and thus avoided
participation in regular physical activity, which may explain
in part the vascular pathology. Also, the study design was of
cross-sectional type therefore we cannot infer causality. Larger
longitudinal studies will be required to conﬁrm this association
and examine the differential associations with various joints.
In conclusion, OA patients have higher risk of subclinical
atherosclerosis independent of traditional risk factors. The
severity of OA may contribute to the progression of athero-
sclerotic disease. These ﬁndings support that OA management
may share preventative approaches with cardiovascular dis-
ease. Measurement of insulin resistance can identify OA pa-
tients with higher risk of subclinical atherosclerosis which
help in their follow up and early intervention.Conﬂict of interest
None.
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